BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24913716)

  • 1. Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray.
    Häggström J; Cipriano M; Forshell LP; Persson E; Hammarsten P; Stella N; Fowler CJ
    Prostate; 2014 Aug; 74(11):1107-17. PubMed ID: 24913716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4.
    Thors L; Bergh A; Persson E; Hammarsten P; Stattin P; Egevad L; Granfors T; Fowler CJ
    PLoS One; 2010 Aug; 5(8):e12275. PubMed ID: 20808855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters.
    Moise AM; Eisenstein SA; Astarita G; Piomelli D; Hohmann AG
    Psychopharmacology (Berl); 2008 Oct; 200(3):333-46. PubMed ID: 18545985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour epithelial expression levels of endocannabinoid markers modulate the value of endoglin-positive vascular density as a prognostic marker in prostate cancer.
    Fowler CJ; Josefsson A; Thors L; Chung SC; Hammarsten P; Wikström P; Bergh A
    Biochim Biophys Acta; 2013 Oct; 1831(10):1579-87. PubMed ID: 23262399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines.
    Brown I; Cascio MG; Wahle KW; Smoum R; Mechoulam R; Ross RA; Pertwee RG; Heys SD
    Carcinogenesis; 2010 Sep; 31(9):1584-91. PubMed ID: 20660502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling.
    Egertová M; Cravatt BF; Elphick MR
    Neuroscience; 2003; 119(2):481-96. PubMed ID: 12770562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour Cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer.
    Fowler CJ; Hammarsten P; Bergh A
    PLoS One; 2010 Dec; 5(12):e15205. PubMed ID: 21203460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between cannabinoid CB₁ receptor expression and Akt signalling in prostate cancer.
    Cipriano M; Häggström J; Hammarsten P; Fowler CJ
    PLoS One; 2013; 8(6):e65798. PubMed ID: 23755281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents.
    Álvaro-Bartolomé M; García-Sevilla JA
    Neuroscience; 2013 Sep; 247():294-308. PubMed ID: 23727505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells.
    Wei Y; Wang X; Wang L
    Mol Vis; 2009 Jun; 15():1243-51. PubMed ID: 19547718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway.
    Ravi J; Sneh A; Shilo K; Nasser MW; Ganju RK
    Oncotarget; 2014 May; 5(9):2475-86. PubMed ID: 24811863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
    Seillier A; Advani T; Cassano T; Hensler JG; Giuffrida A
    Int J Neuropsychopharmacol; 2010 Apr; 13(3):373-86. PubMed ID: 19607756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for both inverse agonism at the cannabinoid CB1 receptor and the lack of an endogenous cannabinoid tone in the rat and guinea-pig isolated ileum myenteric plexus-longitudinal muscle preparation.
    Makwana R; Molleman A; Parsons ME
    Br J Pharmacol; 2010 Jun; 160(3):615-26. PubMed ID: 20590566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury.
    Mukhopadhyay P; Horváth B; Rajesh M; Matsumoto S; Saito K; Bátkai S; Patel V; Tanchian G; Gao RY; Cravatt BF; Haskó G; Pacher P
    Free Radic Biol Med; 2011 Jan; 50(1):179-95. PubMed ID: 21070851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.
    Benito C; Romero JP; Tolón RM; Clemente D; Docagne F; Hillard CJ; Guaza C; Romero J
    J Neurosci; 2007 Feb; 27(9):2396-402. PubMed ID: 17329437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells.
    Cipriano M; Gouveia-Figueira S; Persson E; Nording M; Fowler CJ
    BMC Res Notes; 2014 Jul; 7():441. PubMed ID: 25012825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase.
    Carey LM; Slivicki RA; Leishman E; Cornett B; Mackie K; Bradshaw H; Hohmann AG
    Mol Pain; 2016; 12():. PubMed ID: 27178246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.